NeuroSense Therapeutics (NRSN) Long-Term Investments (2022 - 2025)
NeuroSense Therapeutics' (NRSN) quarterly Long-Term Investments came in at $22000.0 in Q4 2025, down 4.35% year-over-year from $23000.0 in Q4 2024, and down 4.35% quarter-over-quarter from $23000.0 in Q2 2025.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Long-Term Investments (2022 - 2025) Analysis & Trends
NeuroSense Therapeutics has disclosed Long-Term Investments across 4 years of filings, most recently posting $22000.0 for Q4 2025.
- In Q4 2025, Long-Term Investments fell 4.35% year-over-year to $22000.0; the TTM figure through Dec 2025 stood at $22000.0 (down 4.35% YoY), while the FY2025 annual figure was $22000.0, down 4.35% from the prior year.
- Long-Term Investments came in at $22000.0 for Q4 2025 at NeuroSense Therapeutics, down from $23000.0 in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $23000.0 in Q4 2022 to a low of $22000.0 in Q4 2023.
- Average Long-Term Investments over 4 years is $22500.0, with a median of $22500.0 recorded in 2022.
- Year-over-year, Long-Term Investments declined 4.35% in 2023 and advanced 4.55% in 2024.
- Over 4 years, Long-Term Investments stood at $23000.0 in 2022, then dropped by 4.35% to $22000.0 in 2023, then climbed by 4.55% to $23000.0 in 2024, then dropped by 4.35% to $22000.0 in 2025.
- Per Business Quant data, the three most recent Long-Term Investments figures were $22000.0 in Q4 2025, $23000.0 in Q2 2025, and $23000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 5.79 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 9.83 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 1.77 Bn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | -4.00 Mn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 22.17 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | - |
| 10 | NeuroSense Therapeutics | 8.09 Mn | 7.88 Mn | - | 22,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 22,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Dec 31, 2024 | 23,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Dec 31, 2022 | 23,000.00 |
API Access
NeuroSense Therapeutics Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();